Cargando…
Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy
Autores principales: | Hajra, A, Bandyopadhyay, D, Hajra, SK |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664878/ https://www.ncbi.nlm.nih.gov/pubmed/29022566 http://dx.doi.org/10.4103/jpgm.JPGM_434_17 |
Ejemplares similares
-
Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy
por: Dutta, D, et al.
Publicado: (2017) -
Reply to letter to editor regarding the article, “Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy”
por: Dutta, D, et al.
Publicado: (2017) -
Adenosine monophosphate–activated protein kinase in diabetic nephropathy
por: Kim, Yaeni, et al.
Publicado: (2016) -
Diabetic conditions modulate the adenosine monophosphate-activated protein kinase of podocytes
por: Ha, Tae-Sun, et al.
Publicado: (2014) -
Roles of adenosine monophosphate-activated protein kinase (AMPK) in the kidney
por: Zhu, Na, et al.
Publicado: (2022)